CytodynCYDY

13F holders, Q3 2025 (September 30)
11holders
1new positions
1sold out
$0.26avg. 13F price*

At the end of Q3 2025, 11 institutions reported holding Cytodyn Inc. (CYDY) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were Lanark Financial, Inc. ($42K), Diversified Trust Co. ($12K) and Virtue Capital Management, LLC ($12K).

Company
Cytodyn Inc.
CUSIP
23283M101
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 12Q1 2024Q2 2024: 11Q2 2024Q3 2024: 9Q3 2024Q4 2024: 10Q4 2024Q1 2025: 11Q1 2025Q2 2025: 11Q2 2025Q3 2025: 11Q3 2025Q4 2025: 8Q4 2025Q1 2026: 9Q1 2026Q2 2026: 6Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$42K
Exits1$3K

All 13F filers, Q2 2025 → Q3 2025: 160,064 shares bought and 54,600 shares sold, net +105,464 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 11 holders

Lanark Financial, Inc. 0.00% New 160,000 $42K
Diversified Trust Co. 0.00% No change 45,790 $12K
Virtue Capital Management, LLC 0.00% No change 45,000 $12K
Williams Jones Wealth Management, LLC. 0.00% No change 45,001 $12K
RFP Financial Group LLC 0.00% Add +0.1% 44,371 $10K
Next Capital Management LLC 0.00% No change 32,500 $8K
Horizon Financial Services, LLC 0.00% No change 18,200 $5K
FineMark National Bank & Trust 0.00% No change 15,000 $4K
NORTHSTAR ASSET MANAGEMENT Co 0.00% No change 10,000 $3K
Ancora Advisors LLC 0.00% No change 9,488 $2K
Caz Investments LP 0.00% No change 4,000 $1K

"% of holder's portfolio" is CYDY's weight in each manager's 13F, not the share of Cytodyn Inc. the manager owns.